Abstract
Background
Recent population-based studies have highlighted a disproportionate increase in the incidence of rectal cancer among adults younger than aged 50 years. To determine whether different intervention and surveillance strategies might be needed for younger patients, the patterns of care and oncologic outcomes among adults younger than aged 50 years with rectal cancer were investigated.
Methods
A cohort of 333 young (<50 years) patients with sporadic rectal cancer was compared to a contemporaneous cohort of 675 older (>65 years) patients for differences in disease pattern, treatments received, and long-term disease-free survival (DFS).
Results
Patient and tumor characteristics did not differ between groups except for an increased presence of signet-ring and mucinous histology in young patients. Younger patients presented with more advanced-stage disease (stages III and IV: 59.4% vs. 46.4%; p = 0.016). More young patients received sphincter-preservation procedures (63.4 vs. 55.4%; p = 0.016), radiation (61.6 vs. 42.1%; p < 0.001), and chemotherapy (67.3 vs. 47.6%; p < 0.001). Fewer young patients were free from recurrent disease at the last follow-up (72.1 vs. 82.5%; p < 0.001). The stage-specific 5-year DFS did not differ between the young and older cohorts. Only stage and the need for chemotherapy independently predicted poor DFS.
Conclusions
Young patients present at a later stage and a greater proportion develop distant disease recurrence over time. However, their stage-specific oncologic outcomes appear similar to those in older-onset patients. To have the greatest impact on long-term oncologic outcomes in patients with young-onset rectal cancer, future interventions should target strategies to diagnosis rectal cancer earlier, and once diagnosed, closer surveillance for recurrence may be warranted.
Similar content being viewed by others
References
Cancer Facts & Figures 2010. American Cancer Society. www.cancer.org. Accessed July 1, 2010.
Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.
Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18:1695–8.
Endreseth BH, Romundstad P, Myrvold HE, et al. Rectal cancer in the young patient. Dis Colon Rectum. 2006;49:993–1001.
Boardman LA, Johnson RA, Petersen GM, et al. Higher frequency of diploidy in young-onset microsatellite-stable colorectal cancer. Clin Cancer Res. 2007;13:2323–8.
Fernebro E, Halvarsson B, Baldetorp B, et al (2002) Predominance of CIN versus MSI in the development of rectal cancer at young age. BMC Cancer. 2:25.
Nilbert M, Planck M, Fernebro E, et al. Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. Eur J Cancer. 1999;35:942–5.
Boardman LA, Schmidt S, Lindor NM, et al. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair. Genes Chromosomes Cancer. 2001;30:181–6.
Riegert-Johnson DL, Johnson RA, Rabe KG, et al. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing. Genet Test. 2007;11:361–5.
Dozois EJ, Boardman LA, Suwanthanma W, et al. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine (Balt). 2008;87:259–63.
O’Connell JB, Maggard MA, Livingston EH, et al. Colorectal cancer in the young. Am J Surg. 2004;187:343–8.
O’Connell JB, Maggard MA, Liu JH, et al. Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum. 2004;47:2064–9.
Isbister WH, Fraser J. Large-bowel cancer in the young: a national survival study. Dis Colon Rectum. 1990;33:363–6.
McMillan DC, McArdle CS. The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up. Br J Cancer. 2009;101:557–60.
Griffin PM, Liff JM, Greenberg RS, et al. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology. 1991;100:1033–40.
Heys SD, O’Hanrahan TJ, Brittenden J, et al. Colorectal cancer in young patients: a review of the literature. Eur J Surg Oncol. 1994;20:225–31.
Lee PY, Fletcher WS, Sullivan ES, et al. Colorectal cancer in young patients: characteristics and outcome. Am Surg. 1994;60:607–12.
O’Connell JB, Maggard MA, Liu JH, et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg. 2003;69:866–72.
Bleyer A, O’Leary M, Barr R, et al. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. Vol. NIH Pub. No. 06-5767: National Cancer Institute, 2006.
Bulow S. Colorectal cancer in patients less than 40 years of age in Denmark, 1943–1967. Dis Colon Rectum. 1980;23:327–36.
Mitry E, Benhamiche AM, Jouve JL, et al. Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum. 2001;44:380–7.
Nath J, Wigley C, Keighley MR, et al. Rectal cancer in young adults: a series of 102 patients at a tertiary care centre in India. Colorectal Dis. 2009;11:475–9.
Sultan I, Rodriguez-Galindo C, El-Taani H, et al. Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer. 2010;116:758–65.
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95.
U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. AHRS Publication 08-05124-EF-3, October 2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/uspstf08/colocancer/colors.htm.
Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol. 2007;14:2759–65.
Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69–77.
Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–8.
Samowitz WS, Curtin K, Wolff RK, et al. Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009;20:1763–8.
Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247–57.
Jover R, Zapater P, Castells A, et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer. 2009;45:365–73.
Acknowledgment
The authors thank Rui Qin, PhD, for assistance with matching patients in the control cohort of older patients.
Conflict of interest
No disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
You, Y.N., Dozois, E.J., Boardman, L.A. et al. Young-Onset Rectal Cancer: Presentation, Pattern of Care and Long-term Oncologic Outcomes Compared to a Matched Older-Onset Cohort. Ann Surg Oncol 18, 2469–2476 (2011). https://doi.org/10.1245/s10434-011-1674-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-011-1674-7